SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000041
Filing Date
2018-04-05
Accepted
2018-04-05 16:53:45
Documents
5
Period of Report
2018-04-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebio-form8xk2017earnings.htm 8-K 29615
2 EXHIBIT 99.1 ebio-4qye17earningsrelease.htm EX-99.1 33687
3 ebio4qye17earningsrel_image1.gif GRAPHIC 36826
4 ebio4qye17earningsrel_image2.gif GRAPHIC 29841
5 elevenlogoa06.jpg GRAPHIC 8456
  Complete submission text file 0001485003-18-000041.txt   168300
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18741196
SIC: 2834 Pharmaceutical Preparations